Many Medicaid enrollees have restricted access to SGLT2 inhibitors, GLP-1 receptor agonists
Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), ...
Apr 30, 2025
0
0